Duke-NUS Medical School launches a S$20m incubator, LIVE Ventures, to accelerate commercialisation of research.

Duke-NUS Medical School launches LIVE Ventures, a S$20m incubator to accelerate commercialisation of innovative academic research. Focused on translating scientific breakthroughs into clinical applications, LIVE Ventures provides up to S$500k for high-potential projects and partners with public & private entities for co-funding. It aims to bridge the knowledge gap in commercialisation and entrepreneurship, offering mentorship, operational support and product-market fit evaluations.

July 22, 2024
4 Articles